Levocarnitine in Treating Fatigue in Cancer Patients
Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
About this trial
This is an interventional supportive care trial for Fatigue focused on measuring fatigue, unspecified adult solid tumor, protocol specific, levocarnitine, depression, pain, carnitine deficiency
Eligibility Criteria
Inclusion Criteria: Diagnosis of an invasive malignant disorder Moderate to severe fatigue within the past 4 weeks, defined as a score of ≥ 2 (on a scale of 0-4) on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) question "I feel fatigued" Age 18 and over Eastern Cooperative Oncology Group (ECOG) Performance status of 0-3 Negative pregnancy test Fertile patients must use effective contraception during and for 3 months after study participation Exclusion Criteria: Brain metastases Hemoglobin < 9 g/dL, taken <=4 weeks prior to registration Severe, uncontrolled liver disease Evidence of severely compromised renal function including any 1 of the following: Renal failure End stage renal disease Ongoing renal dialysis Severe, uncontrolled cardiovascular disease Severe, uncontrolled pulmonary disease Pregnant or nursing History of seizures Known sensitivity to carnitine Delirium Nausea > grade 1 Taking any form of levocarnitine (L-carnitine) supplementation or nutritional supplements containing carnitine within 2 months prior to registration
Sites / Locations
- Veterans Affairs Medical Center - Palo Alto
- Stanford Comprehensive Cancer Center - Stanford
- Praxair Cancer Center at Danbury Hospital
- Manchester Memorial Hospital
- Lynn Regional Cancer Center at Boca Raton Community Hospital - Main Center
- Baptist Cancer Institute - Jacksonville
- Rush-Copley Cancer Care Center
- St. Joseph Medical Center
- Graham Hospital
- Memorial Hospital
- Eureka Community Hospital
- Evanston Northwestern Healthcare - Evanston Hospital
- Galesburg Clinic, PC
- Galesburg Cottage Hospital
- Mason District Hospital
- Hopedale Medical Complex
- Joliet Oncology-Hematology Associates, Limited - West
- McDonough District Hospital
- BroMenn Regional Medical Center
- Community Cancer Center
- Community Hospital of Ottawa
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
- Cancer Treatment Center at Pekin Hospital
- Proctor Hospital
- CCOP - Illinois Oncology Research Association
- Oncology Hematology Associates of Central Illinois, PC - Peoria
- Methodist Medical Center of Illinois
- OSF St. Francis Medical Center
- Illinois Valley Community Hospital
- Perry Memorial Hospital
- St. Margaret's Hospital
- Carle Cancer Center at Carle Foundation Hospital
- CCOP - Carle Cancer Center
- Elkhart General Hospital
- Howard Community Hospital
- Center for Cancer Therapy at LaPorte Hospital and Health Services
- Saint Anthony Memorial Health Centers
- CCOP - Northern Indiana CR Consortium
- Memorial Hospital of South Bend
- Saint Joseph Regional Medical Center
- McCreery Cancer Center at Ottumwa Regional
- Siouxland Hematology-Oncology Associates, LLP
- Mercy Medical Center - Sioux City
- St. Luke's Regional Medical Center
- Saint Joseph Mercy Cancer Center
- CCOP - Michigan Cancer Research Consortium
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
- Green Bay Oncology, Limited - Escanaba
- Genesys Hurley Cancer Institute
- Hurley Medical Center
- Van Elslander Cancer Center at St. John Hospital and Medical Center
- Dickinson County Healthcare System
- Foote Hospital
- Borgess Medical Center
- West Michigan Cancer Center
- Bronson Methodist Hospital
- Sparrow Regional Cancer Center
- Seton Cancer Institute - Saginaw
- Lakeland Regional Cancer Care Center - St. Joseph
- St. John Macomb Hospital
- Fairview Ridges Hospital
- Mercy and Unity Cancer Center at Mercy Hospital
- Fairview Southdale Hospital
- Mercy and Unity Cancer Center at Unity Hospital
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
- CCOP - Metro-Minnesota
- Park Nicollet Cancer Center
- United Hospital
- Ridgeview Medical Center
- Veterans Affairs Medical Center - East Orange
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
- Veterans Affairs Medical Center - Brooklyn
- Beth Israel Medical Center - Petrie Division
- Mercy Cancer Center at Mercy Medical Center
- Adena Regional Medical Center
- Riverside Methodist Hospital Cancer Care
- CCOP - Columbus
- Grant Medical Center Cancer Care
- Mount Carmel Health - West Hospital
- Doctors Hospital at Ohio Health
- Grady Memorial Hospital
- Fairfield Medical Center
- St. Rita's Medical Center
- Strecker Cancer Center at Marietta Memorial Hospital
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
- Mercy Medical Center
- Community Hospital of Springfield and Clark County
- Mount Carmel St. Ann's Cancer Center
- Genesis - Good Samaritan Hospital
- Natalie Warren Bryant Cancer Center at St. Francis Hospital
- Rosenfeld Cancer Center at Abington Memorial Hospital
- Bryn Mawr Hospital
- Geisinger Medical Center
- Penn State Cancer Institute at Milton S. Hershey Medical Center
- Lewistown Hospital
- Cancer Center of Paoli Memorial Hospital
- Albert Einstein Cancer Center
- Geisinger Medical Group - Scenery Park
- Mount Nittany Medical Center
- Jennersville Regional Hospital
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
- CCOP - MainLine Health
- Lankenau Cancer Center at Lankenau Hospital
- York Cancer Center at Apple Hill Medical Center
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
- Green Bay Oncology, Limited at St. Mary's Hospital
- St. Mary's Hospital Medical Center - Green Bay
- St. Vincent Hospital Regional Cancer Center
- Dean Medical Center - Madison
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
- Bay Area Cancer Care Center at Bay Area Medical Center
- Marshfield Clinic - Marshfield Center
- Green Bay Oncology, Limited - Oconto Falls
- Marshfield Clinic - Indianhead Center
- Green Bay Oncology, Limited - Sturgeon Bay
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Arm I
Arm II
Patients receive oral levocarnitine (L-carnitine) twice daily on weeks 1-4.
Patients receive oral placebo twice daily on weeks 1-4.